345 related articles for article (PubMed ID: 27423214)
1. Interplay between bone and incretin hormones: A review.
Mabilleau G
Morphologie; 2017 Mar; 101(332):9-18. PubMed ID: 27423214
[TBL] [Abstract][Full Text] [Related]
2. Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism.
Hansen MSS; Tencerova M; Frølich J; Kassem M; Frost M
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):25-37. PubMed ID: 28722834
[TBL] [Abstract][Full Text] [Related]
3. Novel extrapancreatic effects of incretin.
Yamada Y; Tsukiyama K; Sato T; Shimizu T; Fujita H; Narita T
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):76-9. PubMed ID: 27186360
[TBL] [Abstract][Full Text] [Related]
4. [Incretin and bone].
Yamada Y
Clin Calcium; 2009 Sep; 19(9):1312-7. PubMed ID: 19721203
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.
Mayer F; Gunawan AL; Tso P; Aponte GW
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358
[TBL] [Abstract][Full Text] [Related]
6. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
Skow MA; Bergmann NC; Knop FK
Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
[TBL] [Abstract][Full Text] [Related]
7. Genetic determinants of circulating GIP and GLP-1 concentrations.
Almgren P; Lindqvist A; Krus U; Hakaste L; Ottosson-Laakso E; Asplund O; Sonestedt E; Prasad RB; Laurila E; Orho-Melander M; Melander O; Tuomi T; Holst JJ; Nilsson PM; Wierup N; Groop L; Ahlqvist E
JCI Insight; 2017 Nov; 2(21):. PubMed ID: 29093273
[TBL] [Abstract][Full Text] [Related]
8. Incretin-based therapy for the treatment of bone fragility in diabetes mellitus.
Mabilleau G; Gobron B; Bouvard B; Chappard D
Peptides; 2018 Feb; 100():108-113. PubMed ID: 29412811
[TBL] [Abstract][Full Text] [Related]
9. Mining incretin hormone pathways for novel therapies.
Wideman RD; Kieffer TJ
Trends Endocrinol Metab; 2009 Aug; 20(6):280-6. PubMed ID: 19595611
[TBL] [Abstract][Full Text] [Related]
10. Incretins Beyond the Pancreas: Exploring the Impact of GIP and GLP-1/2 on Bone Remodeling.
Zhao H; Sun J; Ren Z
Discov Med; 2024 Apr; 36(183):655-665. PubMed ID: 38665015
[TBL] [Abstract][Full Text] [Related]
11. Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.
Opinto G; Natalicchio A; Marchetti P
Arch Physiol Biochem; 2013 Oct; 119(4):170-8. PubMed ID: 23859800
[TBL] [Abstract][Full Text] [Related]
12. Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes.
Bailey CJ; Flatt PR
Peptides; 2024 Apr; 174():171168. PubMed ID: 38320643
[TBL] [Abstract][Full Text] [Related]
13. Nesfatin-1 stimulates glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide secretion from STC-1 cells in vitro.
Ramesh N; Mortazavi S; Unniappan S
Biochem Biophys Res Commun; 2015 Jun; 462(2):124-30. PubMed ID: 25930999
[TBL] [Abstract][Full Text] [Related]
14. [Incretin hormones in the treatment of type 2 diabetes. Part I: influence of insulinotropic gut-derived hormones (incretins) on glucose metabolism].
Matuszek B; Lenart-Lipińska M; Nowakowski A
Endokrynol Pol; 2007; 58(6):522-8. PubMed ID: 18205109
[TBL] [Abstract][Full Text] [Related]
15. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion.
Yan S; Conley JM; Reilly AM; Stull ND; Abhyankar SD; Ericsson AC; Kono T; Molosh AI; Kubal CA; Evans-Molina C; Ren H
Cell Rep; 2022 Jan; 38(1):110179. PubMed ID: 34986353
[TBL] [Abstract][Full Text] [Related]
16. Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.
Kuhre RE; Wewer Albrechtsen NJ; Hartmann B; Deacon CF; Holst JJ
J Diabetes Complications; 2015 Apr; 29(3):445-50. PubMed ID: 25623632
[TBL] [Abstract][Full Text] [Related]
17. Update on incretin hormones.
Phillips LK; Prins JB
Ann N Y Acad Sci; 2011 Dec; 1243():E55-74. PubMed ID: 22545749
[TBL] [Abstract][Full Text] [Related]
18. The biology of incretin hormones.
Drucker DJ
Cell Metab; 2006 Mar; 3(3):153-65. PubMed ID: 16517403
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology, physiology, and mechanisms of incretin hormone action.
Campbell JE; Drucker DJ
Cell Metab; 2013 Jun; 17(6):819-837. PubMed ID: 23684623
[TBL] [Abstract][Full Text] [Related]
20. The incretin system ABCs in obesity and diabetes - novel therapeutic strategies for weight loss and beyond.
João AL; Reis F; Fernandes R
Obes Rev; 2016 Jul; 17(7):553-72. PubMed ID: 27125902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
